# Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females

> **NCT06418347** · PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 150 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Infertility, Female

## Interventions

- **DRUG:** Alpha lipoic acid
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT06418347
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418347, "Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06418347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*